Diagnostic Cytopathology

Papers
(The H4-Index of Diagnostic Cytopathology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Multiplatform molecular test performance in indeterminate thyroid nodules68
The Milan system for reporting salivary gland cytopathology: A comprehensive review of the literature33
Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center31
HEG1, BAP1, and MTAP are useful in cytologic diagnosis of malignant mesothelioma with effusion31
Current applications of molecular testing on body cavity fluids22
Next‐generation sequencing in residual liquid‐based cytology specimens for cancer genome analysis19
Salivary gland fine‐needle aspiration cytology with the application of the Milan system for risk stratification and histological correlation: A retrospective 6‐year study18
Fine‐needle aspiration of parathyroid adenomas: Indications as a diagnostic approach17
The Milan system for reporting salivary gland cytopathology: Single center experience with cell blocks16
Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: An institutional experience16
The continuing role of breast fine‐needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology16
Immunochemistry in the work‐up of mesothelioma and its differential diagnosis and mimickers14
Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study14
Retrospective application of the Milan System for reporting salivary gland cytopathology: A Cancer Center experience14
Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy14
0.058423042297363